Novel Psychoactive Treatment: UK Network (NEPTUNE) II: From guidance to good practice: A multi-dimensional approach to spreading improvement

  • Delivered by the Royal College of Psychiatrists, in partnership with Central and North West London NHS Foundation Trust and other stakeholders.
  • A national learning programme.
  • Aims to improve frontline clinicians’ knowledge and understanding of club drugs; improve detection, assessment and management of acute and chronic harms associated with the use of club drugs; and increase delivery of evidence-based interventions.
  • Targeted, setting-specific, evidence-based resources, with associated tools to be developed.

Contact: Dr Owen Bowden-Jones, Club Drug Clinic and Community Assessment and Primary Services (CAPS)

The use of new drugs known as club drugs, including novel psychoactive substances (NPS) and ‘legal highs’, is increasing. The drugs are associated with significant morbidity, but there is little clinical experience of treating problems resulting from these drugs.

NEPTUNE, a Shine 2012 project, addressed the gap in experience and knowledge in the management of acute and chronic problems resulting from the use of club drugs.

NEPTUNE II aims to maximise the impact of NEPTUNE by influencing the clinical practice of frontline staff, nationwide. It will provide learning resources and tools across a range of health settings, in ways that are convenient and easy to use. It will improve access for people with drug-related harms to specialist, evidence-based treatment.

The NEPTUNE guidance will be turned into setting-specific resources with tools, including template bundles. A learning programme will be developed for each of the target clinical settings: specialist drug treatment services, emergency departments, primary care, mental health services, and sexual health and HIV services.

National clinical data collection tools will be reviewed and developed to facilitate recording of new drugs and improve assessment of need.

The aim is to embed and ‘mainstream’ knowledge about harm resulting from the use of club drugs through a national learning programme and other means such as inclusion in the curricula of key organisations – leading to improved patient outcomes and treatment safety.

The NEPTUNE II team will also work to influence policy-makers to embed the project’s learning into performance management and other national requirements.

An independent evaluation will be carried out during this project and will be published once the project has been completed.

Further reading

Newsletter feature

Improving hospital discharge for dementia patients

‘My Discharge’ was launched at the Royal Free London NHS Foundation Trust in April 2013. Part of the Health Foundation’s 2012...

You might also like...

Press release

Care Quality Commission presents mixed picture of the state of care in England

Our response to the Care Quality Commission’s annual assessment of the state of health and social care in England.

Press release

New funding for diagnostic equipment falls considerably below what is needed

Health Foundation response to the Prime Minister’s announcement of funding for cancer screening.


Preparing young people for tomorrow’s workplace is key to a healthy future

Jo Bibby explores why investing in the future of young people needs to be at the heart of public policy.

Kjell-bubble-diagramArtboard 101

Work with us

We look for talented and passionate individuals as everyone at the Health Foundation has an important role to play.

View current vacancies
Artboard 101 copy 2

The Q Community

Q is an initiative connecting people with improvement expertise across the UK.

Find out more